Clarifying IDSA's Position on Antibiotic Timing in Sepsis: Distinguishing Hospital Strategies from Clinical Guidance
Clinical Infectious Diseases · 18.11.2026
DOI: 10.1093/cid/ciag738 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 18.11.2026. Verfasst von Chanu Rhee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Population Medicine, Harvard Medical School / Harvard Pilgrim Health Care Institute, Boston MA, USA.
Themen: Sepsis
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Population Medicine, Harvard Medical School / Harvard Pilgrim Health Care Institute, Boston MA, USA.
- Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
- Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA.
- Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
ORCID-Profile: Chanu Rhee, Michael Klompas, Henry Masur
Zitieren
APA
Rhee, C., Klompas, M., Masur, H., & Cosgrove, S. E. (2026). Clarifying IDSA's Position on Antibiotic Timing in Sepsis: Distinguishing Hospital Strategies from Clinical Guidance. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciag738
Vancouver
Rhee C, Klompas M, Masur H, Cosgrove SE. Clarifying IDSA's Position on Antibiotic Timing in Sepsis: Distinguishing Hospital Strategies from Clinical Guidance. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciag738
BibTeX
@article{Rhee2026,
author = {Rhee, Chanu and Klompas, Michael and Masur, Henry and Cosgrove, Sara E},
title = {Clarifying IDSA's Position on Antibiotic Timing in Sepsis: Distinguishing Hospital Strategies from Clinical Guidance},
journal = {Clinical Infectious Diseases},
year = {2026},
doi = {10.1093/cid/ciag738}
}
EUVIMED